Table of Contents
ISRN Cell Biology
Volume 2012 (2012), Article ID 142313, 11 pages
http://dx.doi.org/10.5402/2012/142313
Review Article

Cytoskeleton-Associated Protein 4: Functions Beyond the Endoplasmic Reticulum in Physiology and Disease

Department of Basic Sciences, The Commonwealth Medical College, Scranton, PA 18509, USA

Received 21 August 2012; Accepted 19 September 2012

Academic Editors: A. Hergovich and C. M. Wells

Copyright © 2012 Kevin M. Tuffy and Sonia Lobo Planey. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. I. Mundy and G. Warren, “Mitosis and inhibition of intracellular transport stimulate palmitoylation of a 62-kD protein,” Journal of Cell Biology, vol. 116, no. 1, pp. 135–146, 1992. View at Google Scholar · View at Scopus
  2. A. Schweizer, M. Ericsson, T. Bachi, G. Griffiths, and H. P. Hauri, “Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway,” Journal of Cell Science, vol. 104, no. 3, pp. 671–683, 1993. View at Google Scholar · View at Scopus
  3. A. Schweizer, J. Rohrer, H. P. Hauri, and S. Kornfeld, “Retention of p63 in an ER-Golgi intermediate compartment depends on the presence of all three of its domains and on its ability to form oligomers,” Journal of Cell Biology, vol. 126, no. 1, pp. 25–39, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Schweizer, J. Rohrer, P. Jeno, A. De Maio, T. G. Buchman, and H. P. Hauri, “A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation protein,” Journal of Cell Science, vol. 104, no. 3, pp. 685–694, 1993. View at Google Scholar · View at Scopus
  5. A. Schweizer, J. Rohrer, J. W. Slot, H. J. Geuze, and S. Kornfeld, “Reassessment of the subcellular localization of p63,” Journal of Cell Science, vol. 108, no. 6, pp. 2477–2485, 1995. View at Google Scholar · View at Scopus
  6. D. R. C. Klopfenstein, F. Kappeler, and H. P. Hauri, “A novel direct interaction of endoplasmic reticulum with microtubules,” EMBO Journal, vol. 17, no. 21, pp. 6168–6177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Vedrenne, D. R. Klopfenstein, and H. P. Hauri, “Phosphorylation controls CLIMP-63-mediated anchoring of the endoplasmic reticulum to microtubules,” Molecular Biology of the Cell, vol. 16, no. 4, pp. 1928–1937, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Vedrenne and H. P. Hauri, “Morphogenesis of the endoplasmic reticulum: beyond active membrane expansion,” Traffic, vol. 7, no. 6, pp. 639–646, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. R. Klopfenstein, J. Klumperman, A. Lustig, R. A. Kammerer, V. Oorschot, and H. P. Hauri, “Subdomain-specific localization of CLIMP-63 (p63) in the endoplasmic reticulum is mediated by its luminal α-helical segment,” Journal of Cell Biology, vol. 153, no. 6, pp. 1287–1299, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. Razzaq, R. Bass, D. J. Vines, F. Werner, S. A. Whawell, and V. Ellis, “Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4),” Journal of Biological Chemistry, vol. 278, no. 43, pp. 42679–42685, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. T. P. Conrads, G. M. Tocci, B. L. Hood et al., “CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients,” Journal of Biological Chemistry, vol. 281, no. 49, pp. 37836–37843, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Gupta, Y. Manevich, A. S. Kazi, J. Q. Tao, A. B. Fisher, and S. R. Bates, “Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes,” American Journal of Physiology, vol. 291, no. 3, pp. L436–L446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. Matika, M. Wasilewski, J. A. Arnott, and S. L. Planey, “Antiproliferative factor regulates connective tissue growth factor (CTGF/CCN2) expression in T24 bladder carcinoma cells,” Molecular Biology of the Cell, vol. 23, no. 10, pp. 1976–1985, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Planey, S. K. Keay, C. O. Zhang, and D. A. Zacharias, “Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling,” Molecular Biology of the Cell, vol. 20, no. 5, pp. 1454–1463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. M. Shahjee, K. R. Koch, L. Guo, C. O. Zhang, and S. K. Keay, “Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Zacharias, M. Mullen, and S. L. Planey, “Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding,” International Journal of Cell Biology, vol. 2012, Article ID 150918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Karasawa, Q. Wang, L. L. David, and P. S. Steyger, “CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity,” Cell Death and Disease, vol. 1, no. 11, article e102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Kazi, J. Q. Tao, S. I. Feinstein, L. Zhang, A. B. Fisher, and S. R. Bates, “Role of the PI3-kinase signaling pathway in trafficking of the surfactant protein A receptor P63 (CKAP4) on type II pneumocytes,” American Journal of Physiology, vol. 299, no. 6, pp. L794–L807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Vinson, A. Acharya, and E. J. Taparowsky, “Deciphering B-ZIP transcription factor interactions in vitro and in vivo,” Biochimica et Biophysica Acta, vol. 1759, no. 1-2, pp. 4–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. S. C. Li, “Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction,” Biochemical Journal, vol. 390, no. 3, pp. 641–653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Buss and B. M. Sefton, “Direct identification of palmitic acid as the lipid attached to p21(ras),” Molecular and Cellular Biology, vol. 6, no. 1, pp. 116–122, 1986. View at Google Scholar · View at Scopus
  22. J. Zhang, S. L. Planey, C. Ceballos, S. M. Stevens, S. K. Keay, and D. A. Zacharias, “Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method,” Molecular and Cellular Proteomics, vol. 7, no. 7, pp. 1378–1388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Mitchell, A. Vasudevan, M. E. Linder, and R. J. Deschenes, “Protein palmitoylation by a family of DHHC protein S-acyltransferases,” Journal of Lipid Research, vol. 47, no. 6, pp. 1118–1127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Oyama, Y. Miyoshi, K. Koyama et al., “Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis,” Genes Chromosomes and Cancer, vol. 29, no. 1, pp. 9–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Monigatti, B. Hekking, and H. Steen, “Protein sulfation analysis-a primer,” Biochimica et Biophysica Acta, vol. 1764, no. 12, pp. 1904–1913, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Moore, “The biology and enzymology of protein tyrosine O-sulfation,” Journal of Biological Chemistry, vol. 278, no. 27, pp. 24243–24246, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bates, “P63 (CKAP4) as an SP-A receptor: implications for surfactant turnover,” Cellular Physiology and Biochemistry, vol. 25, no. 1, pp. 41–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. K. Keay, Z. Szekely, T. P. Conrads et al., “An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 32, pp. 11803–11808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Kim, S. K. Keay, J. D. Dimitrakov, and M. R. Freeman, “p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells,” FEBS Letters, vol. 581, no. 20, pp. 3795–3799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. H. P. Hauri and A. Schweizer, “The endoplasmic reticulum-Golgi intermediate compartment,” Current Opinion in Cell Biology, vol. 4, no. 4, pp. 600–608, 1992. View at Google Scholar · View at Scopus
  31. J. Lippincott-Schwartz, J. G. Donaldson, A. Schweizer et al., “Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway,” Cell, vol. 60, no. 5, pp. 821–836, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Rickard and T. E. Kreis, “CLIPs for organelle-microtubule interactions,” Trends in Cell Biology, vol. 6, no. 5, pp. 178–183, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Ellis and S. A. Whawell, “Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: evidence for a specific tissue-type plasminogen activator receptor on these cells,” Blood, vol. 90, no. 6, pp. 2312–2322, 1997. View at Google Scholar · View at Scopus
  34. F. Werner, T. M. Razzaq, and V. Ellis, “Tissue plasminogen activator binds to human vascular smooth muscle cells by a novel mechanism. Evidence for a reciprocal linkage between inhibition of catalytic activity and cellular binding,” Journal of Biological Chemistry, vol. 274, no. 31, pp. 21555–21561, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Machovich, K. Ajtai, K. Kolev, and W. G. Owen, “Myosin as cofactor and substrate in fibrinolysis,” FEBS Letters, vol. 407, no. 1, pp. 93–96, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Kranenburg, B. Bouma, L. M. J. Kroon-Batenburg et al., “Tissue-type plasminogen activator is a multiligand cross-β structure receptor,” Current Biology, vol. 12, no. 21, pp. 1833–1839, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. A. Hembrough, K. R. Kralovich, L. Li, and S. L. Gonias, “Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation,” Biochemical Journal, vol. 317, no. 3, pp. 763–769, 1996. View at Google Scholar · View at Scopus
  38. S. R. Bates, A. S. Kazi, J. Q. Tao et al., “Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes,” American Journal of Physiology, vol. 295, no. 4, pp. L658–L669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Keay, M. Kleinberg, C. O. Zhang, M. K. Hise, and J. W. Warren, “Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production,” Journal of Urology, vol. 164, no. 6, pp. 2112–2118, 2000. View at Google Scholar · View at Scopus
  40. W. G. Deng, Y. Zhu, A. Montero, and K. K. Wu, “Quantitative analysis of binding of transcription factor complex to biotinylated DNA probe by a streptavidin-agarose pulldown assay,” Analytical Biochemistry, vol. 323, no. 1, pp. 12–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Van Dusen, L. Yee, L. M. McNally, and M. T. McNally, “A glycine-rich domain of hnRNP H/F promotes nucleocytoplasmic shuttling and nuclear import through an interaction with transportin 1,” Molecular and Cellular Biology, vol. 30, no. 10, pp. 2552–2562, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Cokol, R. Nair, and B. Rost, “Finding nuclear localization signals,” EMBO Reports, vol. 1, no. 5, pp. 411–415, 2000. View at Google Scholar · View at Scopus
  43. S. C. Wang and M. C. Hung, “Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors,” Clinical Cancer Research, vol. 15, no. 21, pp. 6484–6489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Kumeta, S. H. Yoshimura, J. Hejna, and K. Takeyasu, “Nucleocytoplasmic shuttling of cytoskeletal proteins: molecular mechanism and biological significance,” International Journal of Cell Biology, vol. 2012, Article ID 494902, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Keay, C. O. Zhang, J. L. Shoenfelt, and T. C. Chai, “Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis,” Urology, vol. 61, no. 6, pp. 1278–1284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. K. R. Koch, C. O. Zhang, P. Kaczmarek et al., “The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion,” Investigational New Drugs, vol. 30, no. 5, pp. 1849–1864, 2012. View at Google Scholar
  47. S. Keay, F. Seillier-Moiseiwitsch, C. O. Zhang, T. C. Chai, and J. Zhang, “Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment,” Physiological Genomics, vol. 14, pp. 107–115, 2003. View at Google Scholar · View at Scopus
  48. C. O. Zhang, J. Y. Wang, K. R. Koch, and S. Keay, “Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis,” Journal of Urology, vol. 174, no. 6, pp. 2382–2387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Keay, S. Leitzell, A. Ochrzcin, G. Clements, M. Zhan, and D. Johnson, “A mouse model for interstitial cystitis/painfulbladder syndrome based on APF inhibition ofbladder epithelial repair: a pilot study,” BMC Urology, vol. 12, no. 1, 17 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. S. R. Bates, C. Dodia, J. Q. Tao, and A. B. Fisher, “Surfactant protein-A plays an important role in lung surfactant clearance: evidence using the surfactant protein-A gene-targeted mouse,” American Journal of Physiology, vol. 294, no. 2, pp. L325–L333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. S. R. Bates, J. Q. Tao, K. Notarfrancesco, K. DeBolt, H. Shuman, and A. B. Fisher, “Effect of surfactant protein A on granular pneumocyte surfactant secretion in vitro,” American Journal of Physiology, vol. 285, no. 5, pp. L1055–L1065, 2003. View at Google Scholar · View at Scopus
  52. Y. Kuroki, R. J. Mason, and D. R. Voelker, “Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells,” Journal of Biological Chemistry, vol. 263, no. 7, pp. 3388–3394, 1988. View at Google Scholar · View at Scopus
  53. T. Kagawa, L. Varticovski, Y. Sai, and I. M. Arias, “Mechanism by which cAMP activates PI3-kinase and increases bile acid secretion in WIF-B9 cells,” American Journal of Physiology, vol. 283, no. 6, pp. C1655–C1666, 2002. View at Google Scholar · View at Scopus
  54. C. R. L. Webster and M. S. Anwer, “Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver Ntcp,” American Journal of Physiology, vol. 277, no. 6, pp. G1165–G1172, 1999. View at Google Scholar · View at Scopus
  55. G. Tzivion, Y. H. Shen, and J. Zhu, “14-3-3 Proteins; bringing new definitions to scaffolding,” Oncogene, vol. 20, no. 44, pp. 6331–6338, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Wesierska-Gadek, S. B. Hajek, B. Sarg, S. Wandl, E. Walzi, and H. Lindner, “Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1503–1514, 2008. View at Publisher · View at Google Scholar · View at Scopus